Heidi’s move into evidence-based decision support and clinical pathways combined with a new age of AI driven software development confirms what many have suspected: they are going wide and no incumbent medical software vendor is safe.
Heidi’s move into evidence-based decision support and clinical pathways combined with a new age of AI driven software development confirms what many have suspected: they are going wide and no incumbent medical software vendor is safe.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.